At Ab Initio Pharma, we are committed to empowering pharmaceutical companies by offering comprehensive contract development and manufacturing (CDMO) services tailored to complex dosage forms. From early-stage development through to clinical and registration, we specialise in delivering cGMP-compliant solutions that ensure product quality, safety, and regulatory compliance.
| Website | https://www.ab-initio-pharma.com/ |
| Employees | 17 (8 on RocketReach) |
| Founded | 2019 |
| Phone | +61 403 771 606 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Contract Development Manufacturing, Cdmo Services, Pharmaceutical Development, Contract Manufacturing Organization, Pharmaceutical Cdmo, Drug Development, Clinical Manufacturing, Pharmaceutical Manufacturing, Drug Manufacturing, Clinical Trial Manufacturing, Drug Product Development, Cgmp Manufacturing, Dosage Form Development, Custom Pharmaceutical Manufacturing, Drug Formulation, Pharmaceutical Services, Api Manufacturing |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen +46 more (view full list) |
Looking for a particular Ab Initio Pharma employee's phone or email?
Hui Ong is the Chief Scientific Officer of Ab Initio Pharma.
8 people are employed at Ab Initio Pharma.
Ab Initio Pharma is based in Camperdown, New South Wales.